Cargando…

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer

BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, Johanna S. M., Brunnström, Hans, Jabs, Verena, Edlund, Karolina, Jirström, Karin, Mindus, Stephanie, la Fleur, Linnéa, Pontén, Fredrik, Karlsson, Mats G., Karlsson, Christina, Koyi, Hirsh, Brandén, Eva, Botling, Johan, Helenius, Gisela, Micke, Patrick, Svensson, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974795/
https://www.ncbi.nlm.nih.gov/pubmed/27495736
http://dx.doi.org/10.1186/s12885-016-2646-x
_version_ 1782446613086601216
author Mattsson, Johanna S. M.
Brunnström, Hans
Jabs, Verena
Edlund, Karolina
Jirström, Karin
Mindus, Stephanie
la Fleur, Linnéa
Pontén, Fredrik
Karlsson, Mats G.
Karlsson, Christina
Koyi, Hirsh
Brandén, Eva
Botling, Johan
Helenius, Gisela
Micke, Patrick
Svensson, Maria A.
author_facet Mattsson, Johanna S. M.
Brunnström, Hans
Jabs, Verena
Edlund, Karolina
Jirström, Karin
Mindus, Stephanie
la Fleur, Linnéa
Pontén, Fredrik
Karlsson, Mats G.
Karlsson, Christina
Koyi, Hirsh
Brandén, Eva
Botling, Johan
Helenius, Gisela
Micke, Patrick
Svensson, Maria A.
author_sort Mattsson, Johanna S. M.
collection PubMed
description BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohistochemistry (IHC) is often used as screening tool in clinical practice. In order to unbiasedly analyze the diagnostic impact of such a screening strategy, we compared ALK IHC with ALK FISH in three large representative Swedish NSCLC cohorts incorporating clinical parameters and gene expression data. METHODS: ALK rearrangements were detected using FISH on tissue microarrays (TMAs), including tissue from 851 NSCLC patients. In parallel, ALK protein expression was detected using IHC, applying the antibody clone D5F3 with two different protocols (the FDA approved Ventana CDx assay and our in house Dako IHC protocol). Gene expression microarray data (Affymetrix) was available for 194 patients. RESULTS: ALK rearrangements were detected in 1.7 % in the complete cohort and 2.0 % in the non-squamous cell carcinoma subgroup. ALK protein expression was observed in 1.8 and 1.4 % when applying the Ventana assay or the in house Dako protocol, respectively. The specificity and accuracy of IHC was high (> 98 %), while the sensitivity was between 69 % (Ventana) and 62 % (in house Dako protocol). Furthermore, only 67 % of the ALK IHC positive cases were positive with both IHC assays. Gene expression analysis revealed that 6/194 (3 %) tumors showed high ALK gene expression (≥ 6 AU) and of them only three were positive by either FISH or IHC. CONCLUSION: The overall frequency of ALK rearrangements based on FISH was lower than previously reported. The sensitivity of both IHC assays was low, and the concordance between the FISH and the IHC assays poor, questioning current strategies to screen with IHC prior to FISH or completely replace FISH by IHC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2646-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4974795
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49747952016-08-06 Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena Edlund, Karolina Jirström, Karin Mindus, Stephanie la Fleur, Linnéa Pontén, Fredrik Karlsson, Mats G. Karlsson, Christina Koyi, Hirsh Brandén, Eva Botling, Johan Helenius, Gisela Micke, Patrick Svensson, Maria A. BMC Cancer Research Article BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohistochemistry (IHC) is often used as screening tool in clinical practice. In order to unbiasedly analyze the diagnostic impact of such a screening strategy, we compared ALK IHC with ALK FISH in three large representative Swedish NSCLC cohorts incorporating clinical parameters and gene expression data. METHODS: ALK rearrangements were detected using FISH on tissue microarrays (TMAs), including tissue from 851 NSCLC patients. In parallel, ALK protein expression was detected using IHC, applying the antibody clone D5F3 with two different protocols (the FDA approved Ventana CDx assay and our in house Dako IHC protocol). Gene expression microarray data (Affymetrix) was available for 194 patients. RESULTS: ALK rearrangements were detected in 1.7 % in the complete cohort and 2.0 % in the non-squamous cell carcinoma subgroup. ALK protein expression was observed in 1.8 and 1.4 % when applying the Ventana assay or the in house Dako protocol, respectively. The specificity and accuracy of IHC was high (> 98 %), while the sensitivity was between 69 % (Ventana) and 62 % (in house Dako protocol). Furthermore, only 67 % of the ALK IHC positive cases were positive with both IHC assays. Gene expression analysis revealed that 6/194 (3 %) tumors showed high ALK gene expression (≥ 6 AU) and of them only three were positive by either FISH or IHC. CONCLUSION: The overall frequency of ALK rearrangements based on FISH was lower than previously reported. The sensitivity of both IHC assays was low, and the concordance between the FISH and the IHC assays poor, questioning current strategies to screen with IHC prior to FISH or completely replace FISH by IHC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2646-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-05 /pmc/articles/PMC4974795/ /pubmed/27495736 http://dx.doi.org/10.1186/s12885-016-2646-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mattsson, Johanna S. M.
Brunnström, Hans
Jabs, Verena
Edlund, Karolina
Jirström, Karin
Mindus, Stephanie
la Fleur, Linnéa
Pontén, Fredrik
Karlsson, Mats G.
Karlsson, Christina
Koyi, Hirsh
Brandén, Eva
Botling, Johan
Helenius, Gisela
Micke, Patrick
Svensson, Maria A.
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title_full Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title_fullStr Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title_full_unstemmed Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title_short Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
title_sort inconsistent results in the analysis of alk rearrangements in non-small cell lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974795/
https://www.ncbi.nlm.nih.gov/pubmed/27495736
http://dx.doi.org/10.1186/s12885-016-2646-x
work_keys_str_mv AT mattssonjohannasm inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT brunnstromhans inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT jabsverena inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT edlundkarolina inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT jirstromkarin inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT mindusstephanie inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT lafleurlinnea inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT pontenfredrik inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT karlssonmatsg inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT karlssonchristina inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT koyihirsh inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT brandeneva inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT botlingjohan inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT heleniusgisela inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT mickepatrick inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer
AT svenssonmariaa inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer